- Previous Close
51.250 - Open
51.800 - Bid 50.300 x --
- Ask 50.300 x --
- Day's Range
50.200 - 51.800 - 52 Week Range
28.750 - 58.000 - Volume
2,254,600 - Avg. Volume
4,011,854 - Market Cap (intraday)
50.997B - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
26.45 - EPS (TTM)
1.900 - Earnings Date --
- Forward Dividend & Yield 0.48 (0.93%)
- Ex-Dividend Date Jun 17, 2024
- 1y Target Est
61.52
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
www.xajuzi.com1,512
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2367.HK
View MorePerformance Overview: 2367.HK
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2367.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2367.HK
View MoreValuation Measures
Market Cap
51.00B
Enterprise Value
44.55B
Trailing P/E
26.38
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.45
Price/Book (mrq)
8.03
Enterprise Value/Revenue
9.39
Enterprise Value/EBITDA
19.35
Financial Highlights
Profitability and Income Statement
Profit Margin
39.65%
Return on Assets (ttm)
21.27%
Return on Equity (ttm)
37.14%
Revenue (ttm)
4.46B
Net Income Avi to Common (ttm)
1.77B
Diluted EPS (ttm)
1.900
Balance Sheet and Cash Flow
Total Cash (mrq)
6.06B
Total Debt/Equity (mrq)
0.02%
Levered Free Cash Flow (ttm)
2.28B